111 related articles for article (PubMed ID: 10571044)
1. Molecular cloning and characterization of a novel cbl-family gene, cbl-c.
Kim M; Tezuka T; Suziki Y; Sugano S; Hirai M; Yamamoto T
Gene; 1999 Oct; 239(1):145-54. PubMed ID: 10571044
[TBL] [Abstract][Full Text] [Related]
2. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development.
Meisner H; Daga A; Buxton J; Fernández B; Chawla A; Banerjee U; Czech MP
Mol Cell Biol; 1997 Apr; 17(4):2217-25. PubMed ID: 9121472
[TBL] [Abstract][Full Text] [Related]
3. cbl-3: a new mammalian cbl family protein.
Keane MM; Ettenberg SA; Nau MM; Banerjee P; Cuello M; Penninger J; Lipkowitz S
Oncogene; 1999 Jun; 18(22):3365-75. PubMed ID: 10362357
[TBL] [Abstract][Full Text] [Related]
4. D-Cbl, the Drosophila homologue of the c-Cbl proto-oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites.
Hime GR; Dhungat MP; Ng A; Bowtell DD
Oncogene; 1997 Jun; 14(22):2709-19. PubMed ID: 9178769
[TBL] [Abstract][Full Text] [Related]
5. The Cbl family of signal transduction molecules.
Smit L; Borst J
Crit Rev Oncog; 1997; 8(4):359-79. PubMed ID: 9622055
[TBL] [Abstract][Full Text] [Related]
6. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl.
Yoon CH; Lee J; Jongeward GD; Sternberg PW
Science; 1995 Aug; 269(5227):1102-5. PubMed ID: 7652556
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene.
Keane MM; Rivero-Lezcano OM; Mitchell JA; Robbins KC; Lipkowitz S
Oncogene; 1995 Jun; 10(12):2367-77. PubMed ID: 7784085
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl.
Take H; Watanabe S; Takeda K; Yu ZX; Iwata N; Kajigaya S
Biochem Biophys Res Commun; 2000 Feb; 268(2):321-8. PubMed ID: 10679202
[TBL] [Abstract][Full Text] [Related]
9. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif.
Blake TJ; Shapiro M; Morse HC; Langdon WY
Oncogene; 1991 Apr; 6(4):653-7. PubMed ID: 2030914
[TBL] [Abstract][Full Text] [Related]
10. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation.
Thien CB; Walker F; Langdon WY
Mol Cell; 2001 Feb; 7(2):355-65. PubMed ID: 11239464
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line.
Bisson SA; Ujack EE; Robbins SM
Oncogene; 2002 May; 21(23):3677-87. PubMed ID: 12032836
[TBL] [Abstract][Full Text] [Related]
12. Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation.
Yoon CH; Chang C; Hopper NA; Lesa GM; Sternberg PW
Mol Biol Cell; 2000 Nov; 11(11):4019-31. PubMed ID: 11071924
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn.
Ishino M; Ohba T; Sasaki H; Sasaki T
Oncogene; 1995 Dec; 11(11):2331-8. PubMed ID: 8570184
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation.
Elly C; Witte S; Zhang Z; Rosnet O; Lipkowitz S; Altman A; Liu YC
Oncogene; 1999 Feb; 18(5):1147-56. PubMed ID: 10022120
[TBL] [Abstract][Full Text] [Related]
15. The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.
Miyake S; Lupher ML; Andoniou CE; Lill NL; Ota S; Douillard P; Rao N; Band H
Crit Rev Oncog; 1997; 8(2-3):189-218. PubMed ID: 9570294
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.
Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL
J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266
[TBL] [Abstract][Full Text] [Related]
17. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin.
Feshchenko EA; Smirnova EV; Swaminathan G; Teckchandani AM; Agrawal R; Band H; Zhang X; Annan RS; Carr SA; Tsygankov AY
Oncogene; 2004 Jun; 23(27):4690-706. PubMed ID: 15107835
[TBL] [Abstract][Full Text] [Related]
18. Cloning, mapping, and characterization of the human sorbin and SH3 domain containing 1 (SORBS1) gene: a protein associated with c-Abl during insulin signaling in the hepatoma cell line Hep3B.
Lin WH; Huang CJ; Liu MW; Chang HM; Chen YJ; Tai TY; Chuang LM
Genomics; 2001 May; 74(1):12-20. PubMed ID: 11374898
[TBL] [Abstract][Full Text] [Related]
19. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD
Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
